Rocket Pharmaceuticals, Inc. (RCKT)
3.11
+0.14
(+4.71%)
USD |
NASDAQ |
May 21, 16:00
3.10
-0.01
(-0.32%)
After-Hours: 19:59
Rocket Pharmaceuticals Total Liabilities (Quarterly) : 47.37M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AnaptysBio, Inc. | 316.94M |
| Arcus Biosciences, Inc. | 473.00M |
| Replimune Group, Inc. | 123.05M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 285.41M |
| Shareholders Equity (Quarterly) | 238.04M |
| Debt to Equity Ratio | 0.104 |
| Current Ratio | 6.124 |
| Net Debt Paydown Yield | 0.04% |